Mongon Thibaut (Thibaut Mongon)

Mongon Thibaut (Thibaut Mongon)

Biography

2022: Appointment of Johnson & Johnson Consumer Health as CEO

On May 11, 2022, it became known that Johnson & Johnson appointed Thibault Mongon as chief executive officer of the consumer health division, which the pharmaceutical giant allocates to a separate company.

As part of the restructuring, Johnson & Johnson is divided into two public companies - one for the production of consumer health products and another for the production of pharmaceuticals and medical devices.

According to the announcement, released November 12, 2021, the planned split will form two public companies - one for the production of consumer health products Consumer Health Company and Johnson & Johnson, specializing in the production of pharmaceuticals and medical devices.

The consumer health goods division will produce household goods and over-the-counter medicines such as Tylenol, Band-Aid, Listerine, Neutrogena and Aveena skin care products, and Johnson's children's products.

The management transition will occur after the completion of the planned separation of companies, which is expected to occur during 2023, taking into account the requirements of the legislation. It is also reported that nominations of directors and additional appointments to senior positions will be determined in the coming months as the planned separation process progresses.

Thibault Mongon, the current head of consumer health, will become the CEO of a separate company, and Paul Rukh, at the branch, will remain in his current position as chief financial officer. Mongon has led J&J's consumer health division since 2019, and Rukh has served as CFO since 2017.

Executive Chairman Alex Gorski said J&J has conducted an outside search for executives, but decided Mongon and Rouch are best suited to lead an autonomous company.^[1]

Notes